Company Overview
| Stock Name | 和美醫療控股有限公司 |
| Stock Code | 01509 |
| Company Full Name | 和美醫療控股有限公司 |
| Industry | 居民服務 |
| Principal Activities | 公司是中國最大的私立婦產科專科醫院集團。 |
| Listing Date | 2015-07-07 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市朝陽區北苑路小關北里A2號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.hemeiyl.com |
| Share Registrar | |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism |
To be extracted
|
| Offer Price | HK$ 7.55 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 159,161,550 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 6.81 |
| First Day Open | HK$ 7.32 |
| First Day Change | -9.80% |
| First Day Volume | 55156400.0 |
| First Day Turnover | 388431000.0 |
Use of Proceeds
| Use of Proceeds | 1、約60%(約815.5百萬港元)用作于北京、廈門、南京、杭州及重慶開設新醫院;
2、約10%(約135.9百萬港元)用作現有醫院的設施升級及增購設備,包括(i)使用新一代產品提升超聲診斷設備;(ii)提升手術室設施及設備;(iii)增購消毒設備;(iv)增購進口綜合分娩床及提升新生兒重癥監護病房設施;(v)提升及增購實驗室設備;及(vi)增購新生兒及兒科服務相關設備;
3、約5%(約68.0百萬港元)用作信息科技系統的升級及改良;
4、約15%(約203.9百萬港元)用作收購新醫院;
5、約10%(約135.9百萬港元)用作營運資金及其他一般企業用途。 |
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
建银国际金融有限公司 CE AJO225
Overall Coordinators (2)
摩根士丹利亚洲有限公司 CE AAD291
建银国际金融有限公司 CE AJO225
Joint Bookrunners (2)
摩根士丹利亚洲有限公司 CE AAD291
建银国际金融有限公司 CE AJO225
Joint Lead Managers (2)
摩根士丹利亚洲有限公司 CE AAD291
建银国际金融有限公司 CE AJO225
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 林玉明 |
| Company Secretary | 張月芬 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 林玉明(28.78%),泰康保險集團股份有限公司(26.44%),Honeycare International Investment Limited(8.15%),林玉榮及關連人士(6.10%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.